Trial Profile
Clinical Trials Insight: 700030231
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 31 Jan 2008
Price :
$35
*
At a glance
- Drugs Hydralazine/isosorbide dinitrate (Primary)
- Indications Heart failure
- Focus Pharmacodynamics; Registrational
- Sponsors NitroMed
- 31 Jan 2008 New trial record.